Neuropsychiatric events and travel: Do antimalarials play a role?

Journal of Travel Medicine

Volumn 7, Issue 5, 2000, Pages 225-227

  Schlagenhauf, Patricia ^a   Steffen, Robert ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; CHLOROQUINE; COUMARIN DERIVATIVE; DIHYDROFOLATE REDUCTASE INHIBITOR; HALOFANTRINE; MEFLOQUINE; PROGUANIL; QUININE; QUINOLINE DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

CHEMOPROPHYLAXIS; CONVULSION; CULTURAL ANTHROPOLOGY; DEPRESSION; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG SAFETY; HUMAN; MALARIA; MENTAL DISEASE; NEUROPSYCHIATRY; NEUROTOXICITY; NONHUMAN; REVIEW; TRAVEL;

EID: 0033762515     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00069     Document Type: Review

References (12)

1. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Study
2. Psychiatric illness and stress
3. Neuropsychiatric problems in 2,500 long-term travelers to the tropics
4. CNS adverse events associated with antimalarial agents
5. Mefloquine for malaria chemoprophylaxis (1992-1998). A review
6. Convulsions associated with prophylactic antimalarial drugs: Implications for people with epilepsy
7. Chloroquine induced mania
8. Mefloquine compared to other chemoprophylactic regimens in tourists visiting East Africa
9. Comparison of adverse events associated with the use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travellers